Get the Stockscreener App
6.97
1.27%
-0.09
After Hours:
6.97
Solid Biosciences Inc stock is traded at $6.97, with a volume of 166.72K.
It is down -1.27% in the last 24 hours and down -21.95% over the past month.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
See More
Previous Close:
$7.06
Open:
$7.01
24h Volume:
166.72K
Relative Volume:
0.44
Market Cap:
$271.32M
Revenue:
$14.79M
Net Income/Loss:
$-96.02M
P/E Ratio:
-1.1285
EPS:
-6.1766
Net Cash Flow:
$-95.70M
1W Performance:
-8.65%
1M Performance:
-21.95%
6M Performance:
-47.67%
1Y Performance:
+176.59%
1-Day Range:
$6.90
$7.2499
1-Week Range:
$6.90
$7.97
52-Week Range:
$1.81
$15.05
Solid Biosciences Inc Stock (SLDB) Company Profile
Name
Solid Biosciences Inc
Sector
Industry
Phone
617-337-4680
Address
500 RUTHERFORD AVENUE, CHARLESTOWN, MA
Solid Biosciences Inc Stock (SLDB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-12-21 | Initiated | Piper Sandler | Neutral |
| May-27-21 | Initiated | Jefferies | Buy |
| Mar-16-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-09-21 | Initiated | Barclays | Overweight |
| Jan-08-21 | Upgrade | Credit Suisse | Underperform → Neutral |
| Jul-28-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| May-07-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-11-19 | Initiated | Evercore ISI | Outperform |
| Aug-29-19 | Downgrade | Citigroup | Neutral → Sell |
| Aug-19-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Aug-16-19 | Upgrade | Chardan Capital Markets | Neutral → Buy |
| May-14-19 | Downgrade | Credit Suisse | Neutral → Underperform |
| May-14-19 | Downgrade | Goldman | Neutral → Sell |
| Feb-08-19 | Upgrade | Citigroup | Sell → Neutral |
| Feb-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Nov-06-18 | Initiated | Citigroup | Sell |
| Sep-06-18 | Initiated | Credit Suisse | Neutral |
View All
Solid Biosciences Inc Stock (SLDB) Latest News
Solid Biosciences' SWOT analysis: DMD therapy stock faces pivotal data - Investing.com
Deerfield Management Company L.P. Series C Lowers Position in Solid Biosciences Inc. (NASDAQ:SLDB) - MarketBeat
Duchenne Muscular Dystrophy Treatment Drugs, Clinical Trials, Pipeline Insights and Companies 2024 - The Globe and Mail
Is Solid Power, Inc. (SLDP) the Most Promising EV Battery Stock According to Analysts? - Insider Monkey
The Trailer for Ryan Coogler’s Horror Film Sinners Is Appealingly Mysterious - Reactor
Sinners: Ryan Coogler’s Latest Gets a Thrilling First Trailer - Cinelinx
Solid Power, Inc. (NASDAQ:SLDP) Stock Position Reduced by Sagefield Capital LP - Defense World
Inspire Investing LLC Boosts Stake in Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World
(SLDB) Trading Signals - Stock Traders Daily
The First Trailer For Ryan Coogler's Sinners Drops Tomorrow - Bleeding Cool News
Solid Biosciences to Participate at Chardan’s 8th Annual Genetic Medicines Conference - GlobeNewswire
Solid Biosciences to Participate at Chardan’s 8th Annual Genetic Medicines Conference - StockTitan
Lysosomal Disease Treatment Market Size, Analysis, Trends, Opportunities 2024-2033 - WhaTech
2,100 Shares in Silicon Laboratories Inc. (NASDAQ:SLAB) Bought by MQS Management LLC - Defense World
Granite Investment Partners LLC Increases Stock Holdings in Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World
Solid Power secures DOE funding for battery tech expansion - Investing.com India
Solid Power Selected by U.S. Department of Energy for Up to $50 Million Award Negotiation for Continuous Production of Sulfide-based Solid Electrolyte Materials for Advanced All-Solid-State Batteries - StockTitan
Acadian Asset Management LLC Takes Position in Solid Biosciences Inc. (NASDAQ:SLDB) - MarketBeat
Silence Therapeutics (NASDAQ:SLN) Sees Unusually-High Trading Volume - Defense World
Solid Biosciences Inc. (NASDAQ:SLDB) Receives Average Rating of "Buy" from Brokerages - MarketBeat
SkinBioTherapeutics Gears Up for Market Launch - TipRanks
Sellas Life Sciences Group Inc (NASDAQ:SLS): A Bull Case Theory - Yahoo Finance
Daiwa Securities Group Inc. Purchases Shares of 545 Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World
Dai ichi Life Insurance Company Ltd Invests $438,000 in Solventum Co. (NYSE:SOLV) - Defense World
Solid Power Inc [SLDP] Insider Activity: An Update for Investors - Knox Daily
Baird positive on Instil Bio’s SYN-2510 development strategy - TipRanks
iTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Texas Permanent School Fund Corp Has $3.42 Million Stock Position in Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World
Arizona State Retirement System Boosts Stock Holdings in Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World
(SLDB) Investment Analysis and Advice - Stock Traders Daily
SLDBSolid Biosciences Inc. Latest Stock News & Market Updates - StockTitan
Solid Biosciences to Participate at the 2024 Cantor Global Healthcare Conference - GlobeNewswire
Solid Biosciences to Participate at the 2024 Cantor Global Healthcare Conference - StockTitan
Solid Biosciences Inc [SLDB] Insider Activity: An Update for Investors - Knox Daily
Solid Biosciences Tracking Long-Term Effects of Duchenne Muscular Dystrophy Gene Therapy in Phase 1/2 IGNITE-DMD Study - CGTLive™
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StockTitan
Solid Biosciences to Participate at Upcoming Investor Conferences - GlobeNewswire
Solid Biosciences to Participate at Upcoming Investor Conferences - Yahoo Finance
Taking the lead: Solid Biosciences Inc (SLDB) - SETE News
How should investors view Solid Biosciences Inc (SLDB)? - US Post News
Cantor Fitzgerald Equities Analysts Increase Earnings Estimates for Solid Biosciences Inc. (NASDAQ:SLDB) - MarketBeat
Analysts Set Solid Biosciences Inc. (NASDAQ:SLDB) PT at $15.67 - MarketBeat
Deadline in Lawsuit for Investors in Solid Biosciences Inc. (NASDAQ: SLDB) Shares Announced by Shareholders Foundation - Newswire
Analysts Set Expectations for Solid Biosciences Inc.'s FY2024 Earnings (NASDAQ:SLDB) - MarketBeat
Understanding the Risks of Investing in Solid Biosciences Inc (SLDB) - Knox Daily
Research Analysts Issue Forecasts for Solid Biosciences Inc.'s Q3 2024 Earnings (NASDAQ:SLDB) - MarketBeat
TuHURA Biosciences and Kintara Therapeutics Announce Kineta Inc. Reopens Enrollment for VISTA-101 Clinical Trial Evaluating KVA12123 in Patients with Advanced Solid Tumor Cancer - PR Newswire
When the Price of (SLDB) Talks, People Listen - Stock Traders Daily
Solid Biosciences’ (SLDB) Buy Rating Reiterated at HC Wainwright - Defense World
Barclays Trims Solid Biosciences (NASDAQ:SLDB) Target Price to $15.00 - Defense World
Solid Biosciences Inc Stock (SLDB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):